Abstract
DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Cell-Free System
-
DNA, Neoplasm / analysis*
-
Drug Resistance, Neoplasm*
-
Genotype
-
Humans
-
Neoplasm, Residual / diagnosis*
-
Neoplasms / blood*
-
Neoplasms / genetics*
-
Neoplasms / pathology